Position in PFE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,726,602
-$657,515 QoQ
Shares Held
113,231
-6.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#835
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GUYASUTA INVESTMENT ADVISORS INC holds $53,362,618 across 9 Drug Manufacturers - General names. PFE ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
102,689 | $26,079,925 | |
| 2 | MRK |
Merck & Co., Inc.
|
65,671 | $8,438,723 | |
| 3 | ABBV |
AbbVie Inc.
|
28,312 | $7,124,431 | |
| 4 | LLY |
ELI LILLY & Co
|
2,574 | $3,087,333 | |
| 5 | PFE |
Pfizer Inc
This page
|
113,231 | $2,726,602 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,071 | $2,654,611 | |
| 7 | NVS |
Novartis AG
|
10,767 | $1,687,404 | |
| 8 | AMGN |
Amgen Inc
|
3,642 | $1,318,841 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,726,602 | 113,231 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,384,117 | 120,517 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,187,473 | 128,011 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,309,495 | 129,886 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $3,164,168 | 130,535 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,361,351 | 132,650 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $3,534,247 | 133,217 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $4,197,631 | 145,046 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,475,192 | 267,162 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $7,499,576 | 270,255 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $7,832,060 | 272,041 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $29,679,952 | 894,783 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $32,899,282 | 896,927 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $36,997,848 | 906,810 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $46,038,832 | 898,494 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $38,690,929 | 884,162 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $46,208,865 | 881,344 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $45,668,180 | 882,136 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $52,403,745 | 887,447 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $38,597,217 | 897,401 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $35,134,821 | 897,212 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $31,737,226 | 875,993 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $31,123,223 | 845,510 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $30,806,977 | 839,428 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $27,470,578 | 840,078 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $27,499,652 | 842,515 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||